Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Systems Investigation of Vaccine Responses in Aging and Frailty
Authors not listed
Yale University · 2023
Abstract
This study will compare the immune response signatures (including immunologic, transcriptomic and metabolomic) of the two influenza vaccines approved for use in adults age 65 and over (Fluad and Fluzone High-Dose).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-18 MST
Cite this
APA
Anonymous. (2023). Systems Investigation of Vaccine Responses in Aging and Frailty. <em>Yale University</em>. https://clinicaltrials.gov/study/NCT05291676
Vancouver
Anonymous. Systems Investigation of Vaccine Responses in Aging and Frailty. Yale University. 2023.
BibTeX
@misc{anon2023System,
title = {Systems Investigation of Vaccine Responses in Aging and Frailty},
author = {Anonymous},
journal = {Yale University},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
National University Hospital, Singapore 2013
Open access · US-GOV
Multi-parameter Immune Profile Associated With the Humoral Response to Influenza Vaccine, Vaxigrip® in Healthy and Frail Elderly Subjects Aged 65-90 Years in Singapore
UConn Health 2019
Open access · US-GOV
Vaccination Efficacy With Metformin in Older Adults: A Pilot Study
Medical University of Vienna 2019
Open access · US-GOV
Characterisation of Cellular and Humoral Immune Responses Following the First Booster Immunisation With the Inactivated, Purified Japanese Encephalitis Vaccine IXIARO® in Elderly Compared to Young Individuals.
Vanderbilt University Medical Center 2019
Open access · US-GOV
Single Cell Molecular Analysis of Influenza Vaccine Induced T Cell Responses in Adults 65 Years of Age or Older
Longeveron Inc. 2016
Open access · US-GOV
Effects of Intravenous Delivery of Lomecel-B (Formerly Allogenic Longeveron Human Mesenchymal Stem Cells (LMSCs)) on VaccinE-Specific Antibody Responses in Subjects With Aging Frailty
Stanford University 2010
Open access · US-GOV